l-alanine

Small moleculeexperimental

Alanine is a non-essential aminoacid encoded by GCU, GCC, GCA, and GCG codons. Besides being a building block of proteins, alanine plays a key role in glucose-alanine cycle. Alanine is medically used as a dietary supplement for conditions such as fructose intolerance, muscle atrophy, low birth weight. — NCATS

Clinical trial activity

14 trials · 22 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 1999 (NCT00005889)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • alanineSupplementation

    alanine supplementation

Chemistry & pharmacology

Loading structure…

SMILES

C[C@H](N)C(O)=O
Mol. weight
89.0932 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • (2s)-2-aminopropanoic acid
  • (2s)-2-aminopropanoic acid
  • alanine
  • alanine
  • alanine
  • alanine
  • alanine
  • alanine
  • alanine
  • alanine
  • e639
  • e639
  • l-2-aminopropionic acid
  • l-2-aminopropionic acid
  • l-alanin
  • l-alanin
  • l-alanine
  • l-alanine
  • l-alanine
  • l-alanine
  • l-alanine
  • l-alpha-alanine
  • l-alpha-alanine
  • l-α-alanine
  • l-α-alanine
  • (s)-2-aminopropanoic acid
  • (s)-2-aminopropanoic acid
  • (s)-alanine
  • (s)-alanine
  • (s)-alanine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01922167N/ANov 1, 2013McGill University
NCT01576003N/AApr 1, 2012Emmaus Medical, Emory University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Cincinnati, University of Colorado, Denver, University of Michigan
NCT01496768N/AJan 1, 2012University of Sao Paulo
NCT01350427N/AAug 1, 2011University of Sao Paulo
NCT01239303N/ADec 1, 2010Maastricht University, Top Institute Food and Nutrition
NCT01051999Phase 2Feb 1, 2010Emmaus Medical, Emory University
NCT01288495N/AFeb 1, 2009Augusta University
NCT00760383N/AJun 1, 2008National Institutes of Health (NIH), University of Oregon
NCT01185210Phase 2Sep 1, 2007Teikyo University, University of Iowa
NCT00780520N/AJun 1, 2007University of Copenhagen
NCT00075894Phase 1Mar 1, 2004Emory University, National Cancer Institute (NCI)
NCT00586885N/AFeb 1, 2004Ajinomoto, Mayo Clinic
NCT00062283Phase 2Mar 1, 2003Cornell University, National Cancer Institute (NCI)
NCT00005889N/AOct 1, 1999Baylor University, National Center for Research Resources (NCRR)
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (22)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Emory UniversityAcademic/Hospital3132004
Emmaus MedicalFor profit2022010
National Cancer Institute (NCI)Government2122003
University of Sao PauloAcademic/Hospital2212011
AjinomotoFor profit1012004
Augusta UniversityAcademic/Hospital1112009
Baylor UniversityAcademic/Hospital1011999
Cornell UniversityAcademic/Hospital1112003
Maastricht UniversityAcademic/Hospital1112010
Mayo ClinicAcademic/Hospital1112004
McGill UniversityAcademic/Hospital1112013
National Center for Research Resources (NCRR)Government1111999
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government1012012
National Institutes of Health (NIH)Government1012008
Teikyo UniversityAcademic/Hospital1012007
Top Institute Food and NutritionAcademic/Hospital1012010
University of CincinnatiAcademic/Hospital1112012
University of Colorado, DenverAcademic/Hospital1012012
University of CopenhagenAcademic/Hospital1112007
University of IowaAcademic/Hospital1112007
22 organizations
Page 1 / 2